Market Overview

The US gastroenterology market is projected to grow from USD 13.8 billion in 2025 to USD 23.4 billion by 2034, at a CAGR of 6.0%. Growth is supported by the high prevalence of gastrointestinal disorders, advanced healthcare infrastructure, significant medical innovation, and high procedural volumes. Demand is rising for therapeutics, endoscopic devices, diagnostics, and minimally invasive interventions for conditions including inflammatory bowel disease, GERD, colorectal cancer, and liver disorders. AI-enhanced endoscopy, capsule endoscopy, precision medicine, telemedicine, and the expansion of ambulatory surgery centers are also shaping the market.

What is the Current Market size and Expected Value By 2034?

The US gastroenterology market is valued at USD 13.8 billion in 2025 and is expected to reach USD 23.4 billion by 2034, advancing at a 6.0% CAGR. Historical data covers 2019–2024, with 2024 as the base year and 2025 as the estimate year. Therapeutics are projected to lead the product type segment, while hospitals are expected to remain the largest end-user. Market statistics are credited to Dimension Market Research.

What Driving growth of the US Gastroenterology Market

• High prevalence of chronic gastrointestinal disorders
• Aging population increases GI disease demand
• Rapid adoption of AI-enabled medical technologies
• Strong investment in pharmaceuticals and devices
• Expansion of ambulatory surgery centers
• Growing demand for early cancer detection
• Personalized and value-based care adoption

US Gastroenterology Market Trends in 2025

Artificial intelligence is moving toward mainstream clinical integration across US gastroenterology. AI-assisted colonoscopy supports real-time polyp detection, while algorithms are increasingly applied to endoscopic imaging, pathology, microbiome datasets, and disease characterization. Capsule endoscopy, advanced visualization, disposable endoscopes, robotic platforms, and precision diagnostics are also supporting technological advancement. Digital health and tele-gastroenterology are expanding access to specialty care, while automated documentation and workflow optimization are helping endoscopy units improve efficiency and patient throughput.

The market is increasingly shaped by value-based and personalized care models emphasizing outcomes, quality, and total cost of care. Minimally invasive procedures are gaining importance because they can support faster recovery and reduce complications. Personalized treatment is expanding through biomarkers, patient data, and predictive models for IBD, liver disorders, and gastrointestinal cancers. At the same time, reimbursement pressure, regulatory complexity, prior authorization, and utilization management remain important market considerations affecting adoption and access to innovative therapies and technologies.

US Gastroenterology Market Segmentation: Trends and Growth Analysis

• By Product Type: Therapeutics, Biologics, Biosimilars, Small Molecules, Diagnostics, Endoscopic Procedures, Imaging, Lab Tests, Devices, Biopsy Tools, Surgical Instruments
• By Route of Administration: Injectables, Oral Medications, Others
• By Drug Type: Branded Drugs, Generic Drugs
• By Application: Inflammatory Bowel Disease (IBD), Gastroesophageal Reflux Disease (GERD), Irritable Bowel Syndrome (IBS), Colorectal Cancer, Liver Disorders
• By End-User: Hospitals, Diagnostic Centers, Retail Pharmacies, Online Pharmacies

Market Analysis by Region

• The US: The US is the single national market covered in the report and represents the largest and most advanced gastroenterology market, supported by high disease prevalence, advanced healthcare infrastructure, innovation, and substantial healthcare expenditure.

Hospitals are projected to hold the largest end-user share because they manage complex procedures, advanced therapeutic endoscopy, acute GI conditions, cancer care, and infusion-based therapies. Ambulatory surgery centers are the fastest-growing end-user segment.

Top US Gastroenterology Companies and Market Leaders

• AbbVie
• Takeda
• Johnson & Johnson / Janssen
• Pfizer
• Salix Pharmaceuticals
• AstraZeneca
• Ironwood Pharmaceuticals
• Amgen
• Biocon Biologics
• Sandoz
• Samsung Bioepis
• Olympus
• Boston Scientific
• Medtronic
• Fujifilm
• GE HealthCare
• Siemens Healthineers
• Philips
• Exact Sciences
• Quest Diagnostics

Future Outlook

The US gastroenterology market is expected to maintain steady expansion through 2034 as chronic gastrointestinal disease prevalence, aging demographics, and demand for advanced care sustain market activity. Therapeutics are positioned as the leading product segment, with biologics and novel small-molecule therapies supporting revenue growth. Technology investment will remain important as AI-enhanced endoscopy, precision diagnostics, digital health, telemedicine, and advanced imaging become increasingly integrated into clinical workflows. Ambulatory surgery centers are expected to gain importance as routine procedures shift toward lower-cost outpatient settings. Investment opportunities also exist in AI diagnostics, remote monitoring, personalized medicine, microbiome analysis, and next-generation endoscopic technologies. However, reimbursement pressures and regulatory complexity will continue influencing commercialization and market access.

Frequently Asked Questions

• What is the US Gastroenterology Market size in 2025?
• What will the US Gastroenterology Market be worth by 2034?
• What is the CAGR of the US Gastroenterology Market?
• Which product type leads the US Gastroenterology Market?
• Why are therapeutics dominant in US gastroenterology?
• Which route of administration has the largest revenue share?
• What is driving AI adoption in US gastroenterology?
• Which application dominates the US Gastroenterology Market?
• Why are ambulatory surgery centers growing in gastroenterology?
• Who are the leading US gastroenterology market players?

About Us

Dimension Market Research (DMR) is a global market intelligence and consulting firm delivering data-driven insights that help organizations make informed strategic decisions. With expertise across 12+ industries and global markets, DMR provides syndicated reports, custom research, competitive analysis, white space analysis, and business strategy consulting.

Our research solutions combine analytical rigor, industry expertise, and forward-looking intelligence to identify opportunities, reduce risks, and support sustainable growth. Trusted by clients across diverse sectors, DMR is committed to delivering accurate, actionable insights that enable businesses to navigate evolving market landscapes with confidence.

Contact Us

Phone USA: +17323699777

Phone India: +919310023843

E-mail: enquiry@dimensionmarketresearch.com

Address USA: 957 Route 33, Suite 12 #308, Hamilton Square, NJ-08690

Address India: D44, Sector 6, Noida 201301, India